Telehealth General Psychiatry Prescribing: What Psychiatrists Can Do in New York

If you’re a psychiatrist or psychiatric nurse practitioner trying to figure out what you can prescribe via telehealth, which state laws actually apply to your practice, or why your PMHNP colleague in Texas has to jump through more hoops than one in New York — you’re not alone. Prescribing regulations in psychiatry are a moving target, especially with telehealth flexibilities and state-by-state scope-of-practice differences creating a compliance maze.

Here’s the reality: prescribing psychiatric medications in 2026 is more accessible than ever through telehealth, but the rules vary drastically depending on your license type and the state where your patient sits. Psychiatrists have universal prescribing authority nationwide, but PMHNPs face anything from full independence to strict physician supervision depending on where they practice. And when it comes to controlled substances — the stimulants, benzodiazepines, and buprenorphine that make up a significant chunk of psychiatric prescribing — federal waivers have kept telehealth doors open, but you need to stay current on DEA rule changes that could tighten requirements.

This guide breaks down what you need to know: federal and state rules for teleprescribing controlled substances, how PMHNP vs MD prescribing authority stacks up in major states, what collaborative agreements actually require, and how reimbursement works for medication management visits. Whether you’re expanding your telehealth practice, navigating multi-state licensure, or just trying to stay compliant, this is your roadmap.

What Psychiatrists Can Prescribe via Telehealth (Federal & State Rules)

The short answer: As a fully licensed psychiatrist, you can prescribe virtually any psychiatric medication through telehealth in 2026, including Schedule II controlled substances like Adderall or Schedule III like buprenorphine — provided you follow federal DEA waivers and state-specific requirements.

Federal Controlled Substance Rules (DEA Waivers Still in Effect)

The Ryan Haight Act normally requires an in-person exam before prescribing controlled substances, but the DEA waived this requirement during the COVID-19 public health emergency. That waiver has been extended through December 31, 2025 and likely beyond, allowing psychiatrists to initiate controlled substance prescriptions via audio-visual telemedicine without ever seeing the patient in person (texasnp.org). This means you can start a new ADHD patient on stimulants after a video evaluation, or prescribe benzodiazepines for anxiety, or initiate buprenorphine for opioid use disorder — all through telehealth.

But watch for DEA rule changes. The DEA proposed new permanent regulations that would require either:

• An in-person exam before prescribing controlled substances, OR
• A ‘special registration’ for telemedicine prescribing with possible 30-day supply limits

As of early 2026, these proposals are still pending and the current waiver remains in effect. Most experts expect mental health treatment to retain flexibility given the access crisis, but psychiatrists should monitor DEA announcements for final rules (www.nixonpeabody.com).

State-Level Teleprescribing Rules

While federal law sets the baseline, states can impose additional restrictions. Here’s what you need to know for the major psychiatric markets:

Florida: One of the most permissive states. Florida law explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (Florida Statute 456.47). You can prescribe stimulants, benzodiazepines, or any psychiatric medication to a Florida patient via video without an in-person visit. The only major prohibition is for long-term pain management via telehealth — mental health treatment is carved out as an exception (www.flsenate.gov).

Texas: Allows telemedicine prescribing if the standard of care is met and the encounter is conducted via real-time audio-video (www.cchpca.org). Texas prohibits teleprescribing opioids for chronic pain but does not restrict psychiatric medications. You can prescribe ADHD stimulants or anxiety medications via telehealth as long as you conduct a proper video evaluation. Texas requires checking the state Prescription Monitoring Program (PMP) before prescribing any controlled substance, telehealth or in-person.

California: Permits prescribing via telehealth as long as you conduct a ‘good faith exam’ — and a video visit qualifies. There’s no special restriction on psychiatric controlled substances. California also requires enrollment in CURES (the state PMP) and checking it before prescribing Schedule II–IV drugs (natlawreview.com).

New York: Recently finalized regulations explicitly allowing controlled substance prescribing via telehealth when consistent with federal law. New York previously required in-person exams but updated its rules in 2025 to align with DEA waivers, meaning you can initiate controlled meds via video (www.nixonpeabody.com). New York does require an in-person visit every 12 months for Medicare patients receiving tele-mental health services (a Medicare billing rule, not a state law), but this hasn’t been enforced during the federal waiver period.

Pennsylvania & Illinois: Both follow federal law on controlled substance prescribing. Neither state has unique prohibitions on psychiatric teleprescribing beyond what the DEA requires. Illinois requires providers to have a mid-level controlled substance license if you’re an NP, but psychiatrists prescribe under their DEA registration as usual.

Standard of Care & Documentation

Every state requires that telehealth visits meet the same standard of care as in-person. For psychiatrists, this means:

• Conducting a thorough evaluation via secure video (mental status exam, history, symptom review)
• Verifying patient identity and location (you must be licensed in the state where the patient is physically located)
• Documenting the encounter with the same detail as an office visit
• Having an emergency protocol in case of a psychiatric crisis during the video session

Many states (Texas, California, New York) explicitly require documenting that the visit was conducted via telemedicine and obtaining patient consent for telehealth treatment. When prescribing controlled substances, document your rationale, that you checked the PMP, and any discussion of risks and alternatives — both for good clinical practice and liability protection.

Bottom line for psychiatrists: You can initiate and manage nearly all psychiatric medications through telehealth in 2026 under current federal waivers, including controlled substances. The key is maintaining your standard of care, checking state PMPs, and staying alert for DEA rule changes expected by late 2024/early 2025.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNP vs Psychiatrist Prescribing Authority: Who Can Do What

This is where things get complicated. Psychiatrists have full prescribing authority everywhere. PMHNPs’ authority depends entirely on state law — and those laws range from total independence to requiring a psychiatrist’s supervision for every prescription.

The Three Categories of NP Practice Authority

States fall into three buckets:

1. Full Practice Authority (FPA) States
PMHNPs can practice independently — no physician collaboration required. They can open their own practice, diagnose patients, and prescribe all medications (including Schedule II stimulants and benzodiazepines) under their own DEA registration. About 34 states now grant full practice authority to experienced NPs (www.nursepractitioneronline.com).

Among major states:

• Washington, Oregon, Arizona, Colorado: Long-time full practice states
• Massachusetts, Kansas, Indiana, Louisiana, Michigan: Transitioned to FPA between 2020–2025

2. Reduced Practice States
PMHNPs have some independence but need a collaborative agreement with a physician to prescribe. The physician doesn’t supervise day-to-day care but must be available for consultation and typically reviews a percentage of charts periodically.

New York fits here: New NPs must practice under a written agreement with a psychiatrist for their first 3,600 hours (about 2 years). After that, they can practice fully independently — no supervision or chart review required (www.jdsupra.com).

Illinois requires 4,000 hours of supervised practice plus 250 hours of continuing education before a PMHNP can apply for Full Practice Authority. Until then, they must have a collaborative agreement and prescriptions are technically under physician delegation (www.nursepractitionerlicense.com).

California is transitioning: as of 2023, experienced NPs (3+ years) can practice in group settings without direct physician supervision (103 NP status). By January 2026, they can become fully independent 104 NPs. New grads still need physician-supervised protocols for at least 3 years (www.rn.ca.gov).

3. Restricted Practice States
PMHNPs must practice under continuous physician supervision or delegation. They cannot prescribe independently at any point in their career unless the law changes.

Texas is the prime example: Every Texas PMHNP must have a written Prescriptive Authority Agreement with a physician to prescribe any medication. The agreement must specify what the NP can prescribe, and the supervising physician is limited to overseeing 7 NPs at once. Texas NPs cannot prescribe Schedule II stimulants in outpatient settings except in very narrow circumstances (www.bon.texas.gov) (www.cchpca.org).

Florida is restricted for psychiatric NPs specifically. While Florida created an ‘autonomous APRN’ category in 2020, it only applies to primary care specialties (family medicine, pediatrics, internal medicine). Psychiatric NPs were explicitly excluded (www.npschools.com). A Florida PMHNP must practice under a physician protocol and, to prescribe psychotropic controlled substances, must have a psychiatrist as their collaborating physician (www.flsenate.gov).

Pennsylvania still requires collaborative agreements for all NPs with no pathway to independence. Bills to grant full practice authority have been introduced but haven’t passed as of 2026 (www.pacnp.org).

What Collaborative Agreements Actually Mean

In states requiring collaboration, these agreements aren’t just a formality — they define what a PMHNP can and cannot do:

Scope Definition: The agreement must list which medications the NP can prescribe. Some states allow broad authority; others require specific drug categories. In Texas and Florida, controlled substance prescribing must be explicitly delegated in writing.

Physician Availability: The supervising physician must be available for consultation. Many states require the agreement to specify response times and backup coverage.

Chart Review: Common requirement across reduced-practice states. Pennsylvania requires the physician to countersign a certain percentage of NP charts (often 100% for Schedule II prescriptions). South Carolina mandates 10% monthly chart review (www.zivianhealth.com).

Meetings: Texas requires monthly face-to-face meetings between the NP and physician for the first 3 years of the agreement, then quarterly thereafter (www.legis.state.tx.us).

State Board Approval: Some states (Kentucky, Florida) require filing the collaborative agreement with the state nursing board. If the physician changes or the NP moves to a new practice site, the agreement must be updated and re-filed — a common pain point in telehealth when NPs work for multiple companies.

The Practical Impact

For PMHNPs, these differences fundamentally affect how you practice:

In full practice states (WA, AZ, NY after 3,600 hrs), you function exactly like a psychiatrist in terms of prescribing — you see patients, make treatment decisions, and prescribe without anyone else’s involvement.

In reduced practice states (PA, IL before FPA), you need a collaborating psychiatrist. This can be expensive (many physicians charge $1,000–3,000/month to collaborate) and limits your autonomy. Finding a collaborator in your specialty can be challenging, especially in underserved areas.

In restricted states (TX, FL for psych), you’re essentially functioning as a physician extender. You can’t hang your own shingle. You work for a practice that provides physician oversight, or you contract with a telehealth company that employs the supervising physician.

For psychiatrists supervising NPs, you need to know your state’s rules about supervision ratios, chart review requirements, and whether you can supervise remotely (most states now allow this for telehealth practices, but some require periodic in-person meetings).

Reimbursement note: Medicare pays NPs at 85% of physician rates when billing under the NP’s own NPI. Some private insurers do the same; others have payment parity laws requiring equal pay. This affects practice economics even in states where NPs have full clinical authority (www.nursepractitioneronline.com).

Medication Management Reimbursement: What You’ll Actually Get Paid

Understanding the economics of psychiatric prescribing is critical, especially if you’re evaluating telehealth platforms or deciding on your payer mix.

Common CPT Codes for Med Management

Psychiatrists typically bill medication management visits using Evaluation & Management (E/M) codes:

• 90792 (Psychiatric Diagnostic Evaluation): Initial 60-minute assessment with medical services. Medicare pays approximately $173 for this code in 2026 (therathink.com).

• 99213 (Established patient, 15–20 minutes): The bread-and-butter med check code. Medicare pays about $92–96 (therathink.com).

• 99214 (Established patient, 25–30 minutes): Higher complexity or longer visit. Medicare pays approximately $125–136 (therathink.com).

If you combine medication management with psychotherapy in the same visit, you can add psychotherapy codes (90833 for 16–37 minutes of therapy, 90836 for 38–52 minutes) which add roughly $80–135 to the base E/M visit.

Medicare Reimbursement Rates (2026)

Medicare rates are the benchmark most insurers reference. Here’s what the 2026 Medicare Physician Fee Schedule pays:

Source: TheraThink 2026 Reimbursement Rates

For PMHNPs: Medicare reimburses nurse practitioners at 85% of physician rates when services are billed under the NP’s NPI. So a PMHNP billing a 99213 would receive about $80 instead of $95.

Private Insurance: Usually Pays More

Commercial insurance rates vary by region and payer, but most pay above Medicare rates — often 120–150% of Medicare in major markets. A psychiatrist in California or New York might get $150–200 for a 99213 from a major commercial plan, compared to Medicare’s $95.

Telehealth parity laws in many states require insurers to reimburse telehealth at the same rate as in-person. Over 40 states have some form of telehealth payment parity for behavioral health:

• Illinois: SB 667 (2021) mandates equal reimbursement for telehealth through at least 2027
• California: AB 744 requires payment parity for telehealth services
• New York: Updated laws in 2021 ensure telehealth coverage and generally equal payment
• Texas: Has coverage requirements but not mandatory payment parity (though most insurers pay equally for mental health)

Medicaid Reimbursement

Medicaid rates are generally lower than Medicare but volumes can be high. For example:

• Florida Medicaid: $60–80 for a 15-minute med check
• California Medi-Cal: Historically about 75% of Medicare rates, though recent investments aim to raise behavioral health pay
• New York Medicaid: Reimburses tele-mental health at parity with in-person

Many state Medicaid programs have added audio-only telehealth reimbursement for mental health services — important for patients without reliable video access. Medicare also covers audio-only mental health visits at the same rate as video through at least 2024.

The Economics of Platform vs DIY Marketing

Here’s where understanding patient acquisition costs becomes critical. Many psychiatrists wonder whether joining a platform like Klarity Health makes financial sense compared to building their own patient base.

The reality of DIY patient acquisition:

When you try to market yourself independently, you’re looking at real all-in costs of $200–500+ per qualified patient once you factor in:

• SEO takes 6–12 months of consistent investment (website development, content, links) before generating meaningful patient flow — most solo providers don’t have the budget or patience
• Google Ads for ‘psychiatrist near me’ or ‘ADHD treatment’ run $15–40+ per click, and most clicks don’t convert to booked appointments. Realistic cost per booked patient through PPC is $200–400+ once you account for click-through rates, appointment no-shows, and campaign testing costs
• Directory listings (Psychology Today, Zocdoc) charge monthly subscription fees ($30–50/month) PLUS you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35–100+ depending on specialty and market), and the monthly platform fee adds up
• Agency/consultant fees if you hire help (typical SEO or digital marketing retainers start at $2,000–5,000/month)
• Staff time to handle and qualify leads, manage campaigns, and deal with no-shows from cold leads

Most solo practitioners spend $3,000–5,000/month on marketing with uncertain results. You might get zero new patients some months, or 20 unqualified inquiries that don’t convert.

How platforms like Klarity Health change the math:

Klarity uses a pay-per-appointment model where providers pay a standard listing fee per new patient lead (similar to how Zocdoc charges per booking, but simpler). The key differences:

• Zero upfront spend: No monthly subscription, no ad budget, no SEO investment
• Pre-qualified patients: Klarity matches patients to your specialty and availability before they’re sent to you — no wasted time on unqualified leads
• No marketing risk: You only pay when a qualified patient actually books with you. That’s guaranteed ROI vs gambling on whether your Google Ads will convert
• Built-in infrastructure: Telehealth platform, EHR, credentialing support — no separate platform costs
• Both insurance and cash-pay flow: Klarity handles insurance credentialing and billing, or you can see cash-pay patients
• Schedule control: You set your availability and only see patients when you want to work

Instead of spending $4,000/month on marketing hoping to get 8–10 new patients (that’s $400–500 per patient), you pay only when patients actually book. For providers starting out or scaling up, this removes all the financial risk of traditional marketing channels.

State-by-State Breakdown: CA, TX, FL, NY, PA, IL

Here’s how prescribing authority and telehealth rules compare in the major psychiatric markets:

California

Psychiatrist Authority: Full independent prescribing, including all controlled substances
PMHNP Authority: Transitioning to independence via AB 890. As of 2023, NPs with 3+ years experience can become ‘103 NPs’ and practice in group settings without physician supervision. By January 2026, experienced NPs can become fully independent ‘104 NPs’ with no oversight (www.rn.ca.gov)
Telehealth Rules: Permits prescribing via telehealth with a ‘good faith exam’ — video qualifies. No special restrictions on psychiatric medications
PDMP: Must enroll in CURES and check before prescribing Schedule II–IV
Market Notes: California has 11+ million residents in mental health shortage areas but a relatively better psychiatrist-to-population ratio (~1:5,300) than TX or FL (www.healingpsychiatryflorida.com)

Texas

Psychiatrist Authority: Full independent prescribing
PMHNP Authority: Restricted — must have a written Prescriptive Authority Agreement with a physician for all prescribing. No independent practice pathway. NPs cannot prescribe Schedule II in outpatient settings except very limited cases (www.bon.texas.gov)
Telehealth Rules: Allows telemedicine prescribing if standard of care met via audio-video. Prohibits teleprescribing Schedule II for chronic pain but mental health treatment is allowed (www.cchpca.org)
Supervision Rules: Physician limited to 7 NPs/PAs; monthly meetings required first 3 years, then quarterly
Market Notes: Severe shortage (380 mental health HPSAs, 1 psychiatrist per ~8,500 residents) (www.healingpsychiatryflorida.com)

Florida

Psychiatrist Authority: Full independent prescribing
PMHNP Authority: Restricted for psychiatric specialty — psych NPs were excluded from 2020’s autonomous practice law and must practice under physician protocol. To prescribe psychotropic controlled substances, must collaborate with a psychiatrist (www.flsenate.gov)
Telehealth Rules: Explicitly allows teleprescribing of controlled substances for psychiatric treatment — one of the most permissive states (www.flsenate.gov)
Controlled Substance Notes: Psych NPs treating mental illness are exempt from the 7-day Schedule II limit that applies to other NPs
Market Notes: Poor psychiatrist ratio (1:9,000 residents), 7.8 million in shortage areas (www.healingpsychiatryflorida.com)

New York

Psychiatrist Authority: Full independent prescribing
PMHNP Authority: Reduced → FPA after experience — NPs need written collaborative agreement for first 3,600 hours (~2 years). After that, fully independent with no supervision or chart review required (www.jdsupra.com)
Telehealth Rules: Updated 2025 regulations allow controlled substance prescribing via telehealth when consistent with federal law. In-person exam requirement defers to DEA waivers (www.nixonpeabody.com)
PDMP: Must check I-STOP registry before prescribing Schedule II–IV
Market Notes: High psychiatrist concentration in NYC (1:2,900 statewide), but upstate regions undersupplied with 197 HPSAs (www.healingpsychiatryflorida.com)

Pennsylvania

Psychiatrist Authority: Full independent prescribing
PMHNP Authority: Reduced practice (no FPA) — must have collaborative agreement indefinitely. Agreement must detail prescribing scope; physician must countersign certain percentage of charts (www.pacnp.org)
Telehealth Rules: No unique state restrictions beyond federal law. Medicaid and major insurers cover telepsychiatry
Market Notes: Mid-range shortage (1:4,586 ratio), 65 psychiatrists needed in HPSAs (www.healingpsychiatryflorida.com)

Illinois

Psychiatrist Authority: Full independent prescribing
PMHNP Authority: Reduced → FPA pathway — NPs must complete 4,000 hours supervised practice + 250 CE hours, then can apply for Full Practice Authority license allowing independent prescribing (www.nursepractitionerlicense.com)
Telehealth Rules: Strong parity law (SB 667) mandating equal reimbursement for telehealth through 2027
Unique: Illinois allows clinical psychologists with specialized training to prescribe limited mental health medications under psychiatrist supervision
Market Notes: 291 practitioners needed to eliminate shortages; good demand in rural areas (www.healingpsychiatryflorida.com)

FAQs: Prescribing in General Psychiatry

Can I prescribe stimulants to new ADHD patients via telehealth in 2026?
Yes, under current federal DEA waivers (extended through December 31, 2025 and likely beyond). You can initiate Schedule II stimulants like Adderall or Vyvanse via audio-video telehealth without an in-person exam. Check your state’s rules — most states allow this for psychiatric treatment, though Texas restricts NPs from prescribing Schedule II in outpatient settings.

Do PMHNPs need a psychiatrist to prescribe in all states?
No. About 34 states now grant full practice authority to experienced NPs, meaning they can prescribe independently including controlled substances. In states like Texas, Florida (for psych), and Pennsylvania, PMHNPs must have a collaborating physician. States like New York and Illinois have transition periods — after 2–4 years of supervised practice, NPs can prescribe independently.

What’s the difference in reimbursement between MDs and NPs?
Medicare pays NPs at 85% of physician rates when billing under the NP’s own NPI. Many private insurers do the same, though some states have payment parity laws requiring equal reimbursement. For example, a Medicare 99213 (15-minute med check) pays a psychiatrist ~$95 and a PMHNP ~$80.

Can I prescribe buprenorphine (Suboxone) via telehealth?
Yes. The federal X-waiver requirement for buprenorphine was eliminated in 2023 — any DEA-registered provider can now prescribe buprenorphine for opioid use disorder. Current telehealth waivers allow initiating buprenorphine via video without an in-person exam. Some states may have additional reporting or training requirements.

What happens if the DEA changes controlled substance telehealth rules?
The DEA has proposed permanent regulations that could require in-person exams or special telemedicine registration for controlled substances. Most experts expect mental health treatment to retain flexibility, but you should monitor DEA announcements. Any changes would likely include transition periods, and practices could adapt by requiring periodic in-person visits or referring patients for local evaluations.

**Do collaborative agreements cost

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship